An in vitro study from the University of North Carolina at Chapel Hill [1] showed that the new drug developed for COVID-19 could cause mutations in mammalian cells. This raises the possibility that molnupiravir can cause cancer. Molnupiravir is the current drug that Merck is requesting the FDA to have Emergency Use Authorization to treat…
Conflicting Studies about Molnupiravir and Mutations
Posted on